Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 38 páginas
Examen

NR293 PHARMACOLOGY FINAL EXAM PART 2 STUDY GUIDE 2025

Document preview thumbnail
Vista previa 4 fuera de 38 páginas

RAPID ACTING INSULIN - -onset: 15 minutes peak: 30-90 minutes insulin lispro (Humalog) insulin aspart (NovoLog) insulin glulisine (Apidra) SHORT ACTING INSULIN - -*onset: 30-60 minutes peak: 2-4 hours* regular insulin (Humulin R) regular insulin (Novolin R) INTERMEDIATE ACTING INSULIN - -*onset: 1-3 hours* *peak: 8 hours* NPH insulin (Humulin N) NPH insulin (Novolin N) LONG-ACTING INSULIN - -*onset: 1-2 hours* *no peak* *duration: 18-24 hours* insulin glargine (Lantus) insulin detemir (Levemir) PRE-MIXED INSULIN - -*onset = 30-60 minutes* *peak: varies* NR293 70% NPH/30% Reg (Humulin 70/30) 70% NPH/30% Reg (Novolin 70/30) 50% NPH/50% Reg (Humulin 50/50) REGULAR INSULIN - -the only insulin that can be administered via IV route used to treat diabetic ketoacidosis or diabetic coma HYPOGLYCEMIA - -occurs when blood glucose is less than 70 mg/dL HYPOGLYCEMIA - SIGNS & SYMPTOMS - -*Early Signs* confusion irritability tremor sweating *Late Signs* hypothermia seizures BLOOD SUGAR MNEMONIC - -HOT AND DRY = SUGAR HIGH COLD AND CLAMMY = GIVE THEM CANDY INSULIN - INDICATIONS - -used for glycemic control of diabetes mellitus (type 1, type 2, gestational) INSULIN THERAPY FOR TYPE 2 DIABETES MELLITUS - INDICATIONS - -when oral antidiabetic medications, diet, and exercise are unable to control blood glucose levels. severe renal or liver disease is present. painful neuropathy is present. undergoing surgery or diagnostic tests. experiencing severe stress such as infection and trauma. NR293 NR293 undergoing emergency treatment of diabetes ketoacidosis (DKA) and hyperosmolar hyperglycemic nonketotic syndrome requiring treatment of hyperkalemia. WHEN MIXING INSULINS - -*clear before cloudy* 1.) inject air into the cloudy vial 2.) inject air into the clear vial 3.) withdraw clear insulin 4.) withdraw cloudy insulin ADA GLYCEMIC GOAL - -hemoglobin A1C level of less than 7% ADA FASTING BLOOD GLUCOSE GOAL - -80- 130 mg/dL SULFONYLUREAS - -second generation oral antidiabetic drugs glipizide (Glucotrol) glyburide (Diabeta) glimepiride (Amaryl) SULFONYLUREAS - MECHANISM OF ACTION - -bind to specific receptors on beta cells in the pancreas to stimulate the release of insulin decrease secretion of glucagon SULFONYLUREAS - INDICATIONS - -for patients who still have functioning beta cells in the pancreas best for early stages of type 2 diabetes SULFONYLUREAS - CONTRAINDICATIONS - -hypoglycemia conditions that predispose to hypoglycemia potential allergy to sulfonamide antibiotics SULFONYLUREAS - ADVERSE EFFECTS - -hypoglycemia NR293 NR293 NR293 weight gain skin rash nausea epigastric fullness heartburn CORTICOSTEROIDS - -can cause an increase in blood glucose levels METFORMIN (GLUCOPHAGE) - INDICATIONS - -first-line oral drug for the treatment of type 2 diabetes also treats polycystic ovary syndrome (PCOS) as an off-label use METFORMIN (GLUCOPHAGE) - MECHANISM OF ACTION - -*decreases insulin resistance* decreases glucose production by the liver decreases glucose absorption from the GI tract METFORMIN (GLUCOPHAGE) - CONTRAINDICATIONS - -patients with renal disease/renal dysfunction *serum creatinine levels* 1.5 mg/dL (males) 1.4 mg/dL (females) alcoholism metabolic acidosis hepatic disease heart failure conditions that predispose to tissue hypoxia and increase the risk for lactic acidosis METFORMIN (GLUCOPHAGE) - INTERACTIONS - -avoid alcohol when taking this medication due to an increased risk for hypoglycermia METFORMIN (GLUCOPHAGE) - ADVERSE EFFECTS - -abdominal bloating NR293 NR293 nausea cramping a feeling of fullness diarrhea metallic taste hypoglycemia reduction in vitamin B12 levels after long-term use lactic acidosis LACTIC ACIDOSIS - SIGNS & SYMPTOMS - -hyperventilation cold and clammy skin muscle pain abdominal pain dizziness irregular heartbeat METFORMIN (GLUCOPHAGE) - PATIENT TEACHING - -take medication with meals to reduce GI upset BASAL-BOLUS THERAPY - -A long-acting insulin (insulin glargine) is used to *mimic the basal secretion of a healthy pancreas* and constant delivery of an amount of insulin then the bolus is used (insulin lispro or insulin apart) to control increases in daily blood glucose levels MAXIMUM DOSE FOR ACE

Vista previa del contenido

NR293



NR293 PHARMACOLOGY FINAL EXAM
PART 2 STUDY GUIDE 2025

RAPID ACTING INSULIN - -onset: 15 minutes

peak: 30-90 minutes

insulin lispro (Humalog)

insulin aspart (NovoLog)

insulin glulisine (Apidra)

SHORT ACTING INSULIN - -*onset: 30-60 minutes

peak: 2-4 hours*

regular insulin (Humulin R)

regular insulin (Novolin R)

INTERMEDIATE ACTING INSULIN - -*onset: 1-3 hours*

*peak: 8 hours*

NPH insulin (Humulin N)

NPH insulin (Novolin N)

LONG-ACTING INSULIN - -*onset: 1-2 hours*

*no peak*

*duration: 18-24 hours*

insulin glargine (Lantus)

insulin detemir (Levemir)

PRE-MIXED INSULIN - -*onset = 30-60 minutes*

*peak: varies*

NR293

,NR293



70% NPH/30% Reg
(Humulin 70/30)

70% NPH/30% Reg
(Novolin 70/30)

50% NPH/50% Reg
(Humulin 50/50)

REGULAR INSULIN - -the only insulin that can be administered via IV route

used to treat diabetic ketoacidosis or diabetic coma

HYPOGLYCEMIA - -occurs when blood glucose is less than 70 mg/dL

HYPOGLYCEMIA - SIGNS & SYMPTOMS - -*Early Signs*
confusion
irritability
tremor
sweating

*Late Signs*
hypothermia
seizures

BLOOD SUGAR MNEMONIC - -HOT AND DRY = SUGAR HIGH

COLD AND CLAMMY = GIVE THEM CANDY

INSULIN - INDICATIONS - -used for glycemic control of diabetes mellitus (type 1, type
2, gestational)

INSULIN THERAPY FOR TYPE 2 DIABETES MELLITUS - INDICATIONS - -when oral
antidiabetic medications, diet, and exercise are
unable to control blood glucose levels.

severe renal or liver disease is present.

painful neuropathy is present.

undergoing surgery or diagnostic tests.

experiencing severe stress such as infection
and trauma.



NR293

,NR293


undergoing emergency treatment of diabetes ketoacidosis (DKA) and hyperosmolar
hyperglycemic
nonketotic syndrome

requiring treatment of hyperkalemia.

WHEN MIXING INSULINS - -*clear before cloudy*

1.) inject air into the cloudy vial

2.) inject air into the clear vial

3.) withdraw clear insulin

4.) withdraw cloudy insulin

ADA GLYCEMIC GOAL - -hemoglobin A1C level of less than 7%

ADA FASTING BLOOD GLUCOSE GOAL - -80- 130 mg/dL

SULFONYLUREAS - -second generation oral antidiabetic drugs

glipizide (Glucotrol)

glyburide (Diabeta)

glimepiride (Amaryl)

SULFONYLUREAS - MECHANISM OF ACTION - -bind to specific receptors on beta
cells in the pancreas to stimulate the release of insulin

decrease secretion of glucagon

SULFONYLUREAS - INDICATIONS - -for patients who still have functioning beta cells
in the pancreas

best for early stages of type 2 diabetes

SULFONYLUREAS - CONTRAINDICATIONS - -hypoglycemia

conditions that predispose to hypoglycemia

potential allergy to sulfonamide antibiotics

SULFONYLUREAS - ADVERSE EFFECTS - -hypoglycemia



NR293

, NR293


weight gain

skin rash

nausea

epigastric fullness

heartburn

CORTICOSTEROIDS - -can cause an increase in blood glucose levels

METFORMIN (GLUCOPHAGE) - INDICATIONS - -first-line oral drug for the treatment
of type 2 diabetes

also treats polycystic ovary syndrome (PCOS) as an off-label use

METFORMIN (GLUCOPHAGE) - MECHANISM OF ACTION - -*decreases insulin
resistance*

decreases glucose production by the liver

decreases glucose absorption from the GI tract

METFORMIN (GLUCOPHAGE) - CONTRAINDICATIONS - -patients with renal
disease/renal dysfunction

*serum creatinine levels*
> 1.5 mg/dL (males)
> 1.4 mg/dL (females)

alcoholism

metabolic acidosis

hepatic disease

heart failure

conditions that predispose to tissue hypoxia and increase the risk for lactic acidosis

METFORMIN (GLUCOPHAGE) - INTERACTIONS - -avoid alcohol when taking this
medication due to an increased risk for hypoglycermia

METFORMIN (GLUCOPHAGE) - ADVERSE EFFECTS - -abdominal bloating



NR293

Información del documento

Subido en
11 de julio de 2025
Número de páginas
38
Escrito en
2024/2025
Tipo
Examen
Contiene
Preguntas y respuestas
$40.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
AlexScorer
2.5
(2)
Vendido
11
Seguidores
0
Artículos
1800
Última venta
2 semanas hace




Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes